Morningstar

Medtronic Receives FDA Clearance for Nellcor(TM) Pulse Oximetry System With Nell-EQ(TM) Intelligent Processor, a New Technology Designed To Improve Reliability Across Diverse ...

This regulatory milestone follows news from earlier this year, when the company announced positive verification study results for its Nellcor™ pulse oximetry system with Nell-EQ™ intelligent processor ...
GlobalData on MSN

Masimo secures FDA approval for OIRD detection on wearable patient monitor

The newly cleared capability uses AI through the smartSET pulse oximetry sensor platform.
Messenger-Inquirer

Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Soo…

Masimo, a Danaher company and a specialty diagnostics solutions innovator of pulse oximetry and other patient monitoring ...

Danaher (DHR) Completes $9.9B Acquisition of Masimo Corporation

Danaher Corporation (NYSE:DHR) is one of the best long term stocks to buy according to hedge funds. On June 10, Danaher completed its acquisition of Masimo Corporation, a specialist in pulse oximetry ...
MassDevice

Masimo gets FDA nod for AI-enabled opioid-induced respiratory depression detection tech

The OIRD detection capability [Image courtesy of Masimo] Masimo, a Danaher (NYSE:DHR) company, today announced FDA clearance for an opioid-induced respiratory depression (OIRD) detection platform.
medtechdive

Susan Kelly

DiveWire guarantees visibility for your news announcements through instant distribution to MedTech Dive’s audience and its 70,000 newsletter subscribers for 21 days.